Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 646.00K | $ 958.00K | $ 2.52M | $ 2.15M | $ 1.63M |
Total Assets | $ 7.27M | $ 7.40M | $ 8.06M | $ 7.25M | $ 3.08M |
Total Debt | $ ― | $ ― | $ ― | $ ― | $ ― |
Net Debt | $ ― | $ ― | $ ― | $ ― | $ ― |
Total Liabilities | $ 17.00K | $ 21.00K | $ 27.00K | $ 48.00K | $ 91.00K |
Stockholders Equity | $ 7.25M | $ 7.38M | $ 8.04M | $ 7.20M | $ 2.99M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |